These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15521062)

  • 1. Solvation influences flap collapse in HIV-1 protease.
    Meagher KL; Carlson HA
    Proteins; 2005 Jan; 58(1):119-25. PubMed ID: 15521062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
    Lee VS; Nimmanpipug P; Aruksakunwong O; Promsri S; Sompornpisut P; Hannongbua S
    J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
    Meagher KL; Carlson HA
    J Am Chem Soc; 2004 Oct; 126(41):13276-81. PubMed ID: 15479081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flap opening mechanism of HIV-1 protease.
    Tóth G; Borics A
    J Mol Graph Model; 2006 May; 24(6):465-74. PubMed ID: 16188477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations of ligand-induced flap closing in HIV-1 protease approach X-ray resolution: establishing the role of bound water in the flap closing mechanism.
    Singh G; Senapati S
    Biochemistry; 2008 Oct; 47(40):10657-64. PubMed ID: 18785756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.
    Wittayanarakul K; Aruksakunwong O; Sompornpisut P; Sanghiran-Lee V; Parasuk V; Pinitglang S; Hannongbua S
    J Chem Inf Model; 2005; 45(2):300-8. PubMed ID: 15807491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
    Kurt N; Scott WR; Schiffer CA; Haliloglu T
    Proteins; 2003 May; 51(3):409-22. PubMed ID: 12696052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical studies of relaxation of a monomeric subunit of HIV-1 protease in water using molecular dynamics.
    Venable RM; Brooks BR; Carson FW
    Proteins; 1993 Apr; 15(4):374-84. PubMed ID: 8460108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restrained molecular dynamics simulations of HIV-1 protease: the first step in validating a new target for drug design.
    Perryman AL; Lin JH; McCammon JA
    Biopolymers; 2006 Jun; 82(3):272-84. PubMed ID: 16508951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute free energies of binding of peptide analogs to the HIV-1 protease from molecular dynamics simulations.
    Bartels C; Widmer A; Ehrhardt C
    J Comput Chem; 2005 Sep; 26(12):1294-305. PubMed ID: 15981257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvation shell structure of cyclooctylpyranone in water solvent and its comparative structure, dynamics and dipole moment in HIV protease.
    Arul Murugan N; Chandra Jha P; Agren H
    Phys Chem Chem Phys; 2009 Aug; 11(30):6482-9. PubMed ID: 19809680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing.
    Sadiq SK; De Fabritiis G
    Proteins; 2010 Nov; 78(14):2873-85. PubMed ID: 20715057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial roles of the subnanosecond local dynamics of the flap tips in the global conformational changes of HIV-1 protease.
    Li D; Ji B; Hwang K; Huang Y
    J Phys Chem B; 2010 Mar; 114(8):3060-9. PubMed ID: 20143801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
    Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
    ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the multiple protein structure pharmacophore method: consistency across three independent HIV-1 protease models.
    Meagher KL; Lerner MG; Carlson HA
    J Med Chem; 2006 Jun; 49(12):3478-84. PubMed ID: 16759090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand conformational and solvation/desolvation free energy in protein-ligand complex formation.
    Kolár M; Fanfrlík J; Hobza P
    J Phys Chem B; 2011 Apr; 115(16):4718-24. PubMed ID: 21466174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational flexibility in the flap domains of ligand-free HIV protease.
    Heaslet H; Rosenfeld R; Giffin M; Lin YC; Tam K; Torbett BE; Elder JH; McRee DE; Stout CD
    Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):866-75. PubMed ID: 17642513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partition of protein solvation into group contributions from molecular dynamics simulations.
    Morreale A; de la Cruz X; Meyer T; Gelpí JL; Luque FJ; Orozco M
    Proteins; 2005 Jan; 58(1):101-9. PubMed ID: 15517587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.